IRAG
MRNA icon

Investment Research & Advisory Group’s Moderna MRNA Stock Holding History

Investment Research & Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$103 – 233
2023
Q3 		$103 Hold
1
– – ﹤0.01% 211
2023
Q2 		$122 Hold
1
– – ﹤0.01% 215
2023
Q1 		$154 Hold
1
– – ﹤0.01% 189
2022
Q4 		$180 Buy
+1
New +$164 ﹤0.01% 188

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Investment Research & Advisory Group's MRNA Position: Q4 2023 in Review

Investment Research & Advisory Group sold out of Moderna (MRNA) in Q4 2023, closing a stake of 1 share — an estimated $103 sold.

Investment Research & Advisory Group first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $180 in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Investment Research & Advisory Group reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Investment Research & Advisory Group sold 1 Moderna share in Q4 2023, an estimated $103.
  • Investment Research & Advisory Group first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • Investment Research & Advisory Group's Moderna position peaked at $180 in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Investment Research & Advisory Group's 13F filing for Q4 2023, filed 18 Jan 2024.